Factors associated with non-fatal heroin overdose: assessing the effect of frequency and route of heroin administration


Dr M. Teresa Brugal Institut Municipal de Salut Pœblica Plaza de Lesseps, 1 08023 Barcelona Spain Tel: + 34 932384545 ext 208 Fax: + 34 932173197 E-mail: tbrugal@imsb.bcn.es



Aims To examine risk factors associated with non-fatal heroin overdose, particularly frequency and route of heroin administration.

Design Data from cross-sectional surveys were analysed as a case–control and as a case cross-over design.

Setting and participants 2556 subjects treated for heroin dependence in 164 outpatient facilities in Spain.

Measurements Prevalence of overdose involving emergency care in the 12 months before treatment admission.

Case control design Odds ratio (OR) adjusted by logistic regression.

Case–crossover design

Estimated relative risk (RR) of transient risk of injecting heroin.

Findings The prevalence of overdose was 10%. In the case control analysis the cumulative risk of overdose increased as the frequency of heroin use decreased. However, among daily heroin users this risk increased as the frequency of heroin injection rose, with an OR of 6.0 (95% CI: 3.9–9.6) for daily injectors versus non-injectors. Sniffers had a higher risk than smokers among non-daily users, but not among daily users. Other factors associated with increased risk of overdose were: tranquillizers, alcohol or cocaine use, living in certain regions and being long-term HIV+ 0. In the case–crossover analysis, the RR for injecting heroin versus using other routes immediately before overdose was 15.9 (95%CI: 9.5–26.6), and was much higher for non-daily heroin users than for daily users.

Conclusions These findings suggest that the rapid entry of a large quantity of heroin into the blood (as occurs when injecting) involves a high risk of overdose, especially when the heroin tolerance level is low (as occurs in sporadic users).